Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,078 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination of oligo-fractionated irradiation with nivolumab can induce immune modulation in gastric cancer.
Mimura K, Ogata T, Nguyen PHD, Roy S, Kared H, Yuan YC, Fehlings M, Yoshimoto Y, Yoshida D, Nakajima S, Sato H, Machida N, Yamada T, Watanabe Y, Tamaki T, Fujikawa H, Inokuchi Y, Hayase S, Hanayama H, Saze Z, Katoh H, Takahashi F, Oshima T, Goel A, Nardin A, Suzuki Y, Kono K. Mimura K, et al. Among authors: watanabe y. J Immunother Cancer. 2024 Jan 30;12(1):e008385. doi: 10.1136/jitc-2023-008385. J Immunother Cancer. 2024. PMID: 38290769 Free PMC article.
Anti-PD-1 monoclonal antibody-resistant esophageal squamous cell carcinoma showing the abscopal effect: A case report with T-cell receptor/B-cell receptor repertoire analysis.
Takehara Y, Mimura K, Suzuki Y, Watanabe Y, Yoshimoto Y, Saze Z, Sato H, Tamaki T, Kono K. Takehara Y, et al. Among authors: watanabe y. Cancer Rep (Hoboken). 2023 Jul;6(7):e1832. doi: 10.1002/cnr2.1832. Epub 2023 May 11. Cancer Rep (Hoboken). 2023. PMID: 37165926 Free PMC article.
Phase I/II clinical trial of nivolumab in combination with oligo-fractionated irradiation for unresectable advanced or recurrent gastric cancer.
Mimura K, Ogata T, Yoshimoto Y, Yoshida D, Nakajima S, Sato H, Machida N, Yamada T, Watanabe Y, Tamaki T, Fujikawa H, Inokuchi Y, Hayase S, Hanayama H, Saze Z, Katoh H, Takahashi F, Oshima T, Suzuki Y, Kono K. Mimura K, et al. Among authors: watanabe y. Commun Med (Lond). 2023 Aug 15;3(1):111. doi: 10.1038/s43856-023-00343-4. Commun Med (Lond). 2023. PMID: 37582945 Free PMC article.
Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer.
Nakayama Y, Mimura K, Kua LF, Okayama H, Min AKT, Saito K, Hanayama H, Watanabe Y, Saito M, Momma T, Saze Z, Ohki S, Suzuki Y, Ichikawa D, Yong WP, Kono K. Nakayama Y, et al. Among authors: watanabe y. Gastric Cancer. 2020 Nov;23(6):961-973. doi: 10.1007/s10120-020-01079-z. Epub 2020 May 4. Gastric Cancer. 2020. PMID: 32367440
[A Case of Laparoscopic Surgery for Preoperatively Diagnosed Gastric Metastasis of Lung Cancer].
Mochizuki S, Yamada L, Kase K, Ito M, Nakano H, Yamauchi N, Matsumoto T, Kaneta A, Kanke Y, Nakajima T, Hanayama H, Watanabe Y, Onozawa H, Hayase S, Okayama H, Fujita S, Sakamoto W, Saito M, Momma T, Saze Z, Mimura K, Ohki S, Kono K. Mochizuki S, et al. Among authors: watanabe y. Gan To Kagaku Ryoho. 2021 Aug;48(8):1057-1060. Gan To Kagaku Ryoho. 2021. PMID: 34404076 Review. Japanese.
Radiation-Induced Remodeling of the Tumor Microenvironment Through Tumor Cell-Intrinsic Expression of cGAS-STING in Esophageal Squamous Cell Carcinoma.
Nakajima S, Mimura K, Kaneta A, Saito K, Katagata M, Okayama H, Saito M, Saze Z, Watanabe Y, Hanayama H, Tada T, Sakamoto W, Momma T, Ohira H, Kono K. Nakajima S, et al. Among authors: watanabe y. Int J Radiat Oncol Biol Phys. 2023 Mar 15;115(4):957-971. doi: 10.1016/j.ijrobp.2022.10.028. Epub 2022 Nov 8. Int J Radiat Oncol Biol Phys. 2023. PMID: 36368436
Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
Nakajima S, Mimura K, Saito K, Thar Min AK, Endo E, Yamada L, Kase K, Yamauchi N, Matsumoto T, Nakano H, Kanke Y, Okayama H, Saito M, Neupane P, Saze Z, Watanabe Y, Hanayama H, Hayase S, Kaneta A, Momma T, Ohki S, Ohira H, Kono K. Nakajima S, et al. Among authors: watanabe y. Mol Cancer Res. 2021 Jun;19(6):1085-1095. doi: 10.1158/1541-7786.MCR-20-0917. Epub 2021 Mar 5. Mol Cancer Res. 2021. PMID: 33674443
12,078 results
You have reached the last available page of results. Please see the User Guide for more information.